These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1266662)

  • 1. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1977; 202(6):517-21. PubMed ID: 339674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of pindolol in hypertensive patients.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand Suppl; 1977; 606():55-62. PubMed ID: 268933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation.
    Gretzer I; Dunér H; Lagerbäck B
    J Hypertens Suppl; 1985 Dec; 3(3):S215-7. PubMed ID: 2856707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Br J Clin Pharmacol; 1982; 13(Suppl 2):259S-267S. PubMed ID: 7104149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension.
    Maarek B; Simon AC; Levenson J; Merli I; Bouthier J
    Clin Pharmacol Ther; 1986 Apr; 39(4):403-8. PubMed ID: 2937599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes.
    Hansson L
    Am J Cardiol; 1986 Feb; 57(5):29C-32C. PubMed ID: 3946248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
    Fitscha P; Meisner W; Brandstetter G; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
    Johnston GD; Finch MB; Shanks RG
    Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    Am Heart J; 1986 Aug; 112(2):368-74. PubMed ID: 2874735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man.
    Maarek BL; Bouthier JA; Simon AC; Levenson JA; Safar ME
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S61-6. PubMed ID: 2427854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.